Logo

Incyte and Pfizer Expand Database Agreement

Dec 21, 1998
Premium

PALO ALTO, Calif.--Maker of genomics database products, Incyte Pharmaceuticals extended for three more years its collaboration with Pfizer and expanded the scope of its original 1994 agreement to allow Pfizer access to a proprietary Incyte database of full-length genes and a DNA clone set. Pfizer will have continued access to the gene sequence and expression database it has contracted since 1994. Financial terms of the agreement were not disclosed.

Filed under

Informatics
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.